ROP
62
-3
TAP
63
-3
COP
48
-5
LRCX
43
-6
PFE
35
-2
MTCH
22
-13
LNC
50
-8
ROK
34
-2
WAT
43
-4
PBI
35
-3
TDC
28
-6
BEN
26
-2
NAVI
32
-4
LEN
11
-3
VMC
62
-4
CNP
70
2
BA
39
-5
HES
68
-2
PNC
59
-2
NTAP
31
-5
ROP
62
-3
TAP
63
-3
COP
48
-5
LRCX
43
-6
PFE
35
-2
MTCH
22
-13
LNC
50
-8
ROK
34
-2
WAT
43
-4
PBI
35
-3
TDC
28
-6
BEN
26
-2
NAVI
32
-4
LEN
11
-3
VMC
62
-4
CNP
70
2
BA
39
-5
HES
68
-2
PNC
59
-2
NTAP
31
-5
Financhill
Back

VanEck Pharmaceutical ETF Stock Predictions

Apple's Drop in iPhone Sales Opens the Door for New Entrant

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
50

PPH
VanEck Pharmaceutical ETF

Last Price:
$90.54
Seasonality Move:
4.46%

7 Day Trial

ALL ACCESS PASS

$ 7

Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

VanEck Pharmaceutical ETF Stock Forecast

  • Over the next 52 weeks, VanEck Pharmaceutical ETF has on average historically risen by 8.7% based on the past 14 years of stock performance.
  • VanEck Pharmaceutical ETF has risen higher in 10 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 71.43%
  • Is VanEck Pharmaceutical ETF Stock Undervalued?
    The current VanEck Pharmaceutical ETF [PPH] share price is $90.65. The Score for PPH is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • PPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will VanEck Pharmaceutical ETF Stock Go Up Next Year?

  • Over the next 52 weeks, VanEck Pharmaceutical ETF has on average historically risen by 8.7% based on the past 14 years of stock performance.

VanEck Pharmaceutical ETF Stock Rating

Sell
50
VanEck Pharmaceutical ETF (PPH) is a Sell

Is VanEck Pharmaceutical ETF overpriced?

  • VanEck Pharmaceutical ETF has risen higher in 10 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 71.43%

VanEck Pharmaceutical ETF Stock Price History

Is PPH stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PPH is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
99.51
52-Week Low:
84.48

Prediction Charts

Market Cap:
0
Price in USD:
90.65
Volume:
159.6K
Beta:
0.56

Technical Analysis

SMA50:
90.41
SMA100:
89.53
SMA200:
91.90
52-Wk Change:
-0.06%

Stock Predictions

  • Is VanEck Pharmaceutical ETF stock public?
    Yes, VanEck Pharmaceutical ETF is a publicly traded company.
  • What is the VanEck Pharmaceutical ETF stock quote today?
    The VanEck Pharmaceutical ETF stock price is 90.65 USD today.
  • How to buy VanEck Pharmaceutical ETF stock online?
    You can buy VanEck Pharmaceutical ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-11 93.32 92.52 93.32 92.22
Mar-12 91.90 91.50 91.97 91.16
Mar-13 91.65 91.59 92.10 91.26
Mar-14 91.20 91.85 91.97 91.09
Mar-17 92.29 93.29 93.47 92.27
Mar-18 93.50 93.48 93.55 92.84
Mar-19 93.43 93.17 93.43 92.70
Mar-20 93.37 93.37 93.60 93.00
Mar-21 92.61 92.64 93.11 92.53
Mar-24 92.20 92.60 92.62 92.20
Mar-25 92.93 90.98 93.10 90.62
Mar-26 90.57 90.32 90.85 90.13
Mar-27 90.14 90.37 90.62 90.13
Mar-28 90.61 90.65 90.81 90.37

VanEck Pharmaceutical ETF Earnings

Data Unavailable

VanEck Pharmaceutical ETF Forecast Revenue Growth

Data Unavailable

* VanEck Pharmaceutical ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.